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Current contribution of four biotechno logies to New Zealand’s primary sector 
 
1. Introduction 
This paper presents an estimate the economic contribution of biotechnology to the 
primary sector in New Zealand. The primary sector is important to the New Zealand 
economy, and  it employs biotechnology for production and processing. 
Biotechnology can be defined in a broad way, as technology applied to biological 
matter. More narrowly, modern biotechnology can refer specifically to techniques 
coming into commercial use after about 1980, when production processes  could begin 
using the smallest parts of organisms, their cells and biological molecules. The 
present research focused on four specific modern biotechnologies and their impacts 
on primary production:  
· Clonal propagation/cell manipulation: clonal propagation using meristem and 
shoot culture, doubling chromosome numbers of cells, embryo rescue, and 
similar techniques. 
· Bio-control agents: bio-pesticides derived from organisms (classical biocontrol 
was not included). 
· Enzyme manipulations: modified catalysts for improving feed quality, waste 
management, textile manufacture and bleaching of wood pulp. 
· Marker-assisted selection: using genotypic information for selection, as opposed 
to older phenotypic selection based on physical traits. 
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2. Prior research 
The impact of technological development on agricultural production has received 
much attention. One particular focus has been the contribution of improved 
germplasm to agricultural output. Agronomic research on staple crops led to 
important increases in production in the second half of the 20th century, and these 
increases have had economic impacts (Evenson and Gollin, 2003). Abeledo, 
Calderini, & Slafer (2002) summarize research on genetic gains in barley. Genetic 
yield gains in barley vary by study, but they are 0.3 per cent to 0.4 per cent per year 
for the whole 20th century. Abeledo, et al. (2002) further note that genetic gains from 
wheat have been slightly higher than those for barley, about 0.5 per cent per year. For 
maize, Duvick & Cooper (2004) demonstrate a clear linear trend in yields per hectare 
since 1930. Interestingly, potential yield per plant has not increased from 1930 to the 
mid-1990s. Instead, newer varieties perform better for harvest index and under stress 
and crop density, leading to increased yields per hectare over time. However, yield 
increases appear to have declined over time (Evenson and Gollin, 2003; Traxler et al., 
1995). It appears that the ‘easy gains’ from traditional breeding techniques had 
already been achieved, so that further gains require more powerful technologies 
(Bajaj, 1990).  
One technology that has received much attention is genetic engineering (GE) or 
genetic modification (GM). The current generation of GM crops tends to affects how 
the crops are produced, particularly with potential increases in yield and/or reductions 
in costs (Caswell et al., 1998; Fernandez-Cornejo and McBride, 2000, 2002; OECD, 
2000). For example, university varietal trials of herbicide-tolerant (Ht) soybeans 
(Benbrook, 1999) and field trials (Marra et al., 2002) indicate lower yields in 1997 
and 1998, while the USDA (Fernandez-Cornejo and McBride, 2002) found small 
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yield increases. Ht soybeans are generally associated with higher use of glyphosate 
herbicide (Roundup), but lower use of other herbicides (European Commission, 2000; 
Duffy, 2001; Fernandez-Cornejo and McBride, 2000; Shoemaker et al., 2001). 
Management and labor effort are lower for Ht crops, because they make the job of 
weed management easier. Farmers can use fewer pesticides and have a wider window 
for their use than with other weed management programs (Benbrook, 2001; European 
Commission, 2000; Duffy, 2001; Fernandez-Cornejo and McBride, 2002; Gianessi et 
al., 2002). Overall, the impact of Ht soybeans on net returns is uncertain, as research 
has found reduced returns (Benbrook, 1999), increased returns (Shoemaker et al., 
2001), and no effect (Duffy, 2001; Fernandez-Cornejo and McBride, 2002; 2001). 
Other specific biotechnologies do not appear to have received the same attention as 
GM. There appears to be little indication in the literature of the impacts on 
agricultural production that may be ascribed to the four biotechnologies considered in 
this research. However, the GM research does suggest that a biotechnology may affect 
two different dimensions of agricultural production (Caswell et al., 1998; Shoemaker 
et al., 2001), as depicted in Figure 1. The first dimension is product quality, or the 
extent to which the primary product is altered by biotechnology. Changes to product 
quality may affect demand  for the product. Furthermore, product differentiation in the 
market may result, possibly leading to a competitive advantage for adopters (Porter, 
1991).  The second dimension is production practices, which considers the similarity 
between the production systems with and without biotechnology. Some innovations 
are simply input substitutes: they replace non-biotech inputs. Other biotechnology 
applications may lead to more radical changes. Any change may be expected to affect 
the cost per unit of output through changes in inputs and yield. They may also affect 
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the configuration of input factors (Barney, 1986) and/or the activity structure (Porter, 
1991) of production.  
[Figure 1] 
 
3. Method 
The method chosen for assessing the contribution of these four biotechnologies was a 
cost-benefit analysis (CBA). However, the data required are not available in official 
statistics or from other public sources. To obtain information for the CBA, the 
research included interviews with expert sources in biotechnology and primary 
production. These interviews provided important data for assessing economic impacts 
of biotechnology. This information was incorporated into the CBA to compare the 
costs and benefits of the biotechnologies. The present research focused on the 
economic impacts, but attempted  to include other types of costs and benefits where 
feasible. The stages in the CBA were: 
· Definition of impacts. This included market and non-market impacts. A key 
consideration was the counterfactual, the situation that would have prevailed in 
the absence of biotechnology, against which the impact of the biotechnology 
was estimated. In addition, the research focused mainly on production rather 
than processing impacts. 
· Identification and estimation of impacts. Information regarding the physical 
impacts formed the basis for calculations of costs and benefits of the 
technology. The net impact was estimated from the gross impact by a 
calculation of the gross margin from production budgets (Burtt, 2004). The 
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research focused on currently commercial biotechnology innovations, so that 
estimates of future impacts were not considered. 
· Consideration of relevant impacts. Relevance criteria include the size of the 
impacts on prices and quan tities, as well as impacts on marketed and non-
marketed goods and services.  
· Discounting of cost and benefit flows. Costs and benefits over time were 
discounted to net p resent value.  
· Application of the net present value test. For successful innovations, benefits 
would be expected to exceed costs. 
· Review of study and assumptions. This study and its underlying assumptions 
have been extensively reviewed by the research team and biotechnology 
stakeholders in New Zealand. 
For analysis, the primary sector was divided by commodity, as reported in Table 1. 
The dairy subsector is the largest for New Zealand, and is centrally organized around 
one firm (Fonterra). Horticulture, including floriculture, is the second largest and 
comprises a wide range of products and farm types. Sheep, beef and veal, and forestry 
subsectors are all largely based on extensive land use practices and tend to be export-
focused. The arable subsector is small relative to the others. Finally, seafood is 
another export-driven area of primary production, and is based on both wild and 
farmed production.  
[Table 1] 
The interviews solicited information from a wide range of individuals, who were 
identified through the New Zealand Biosphere Website 
(http://www.biospherenz.com/) and discussions with Government agencies. This 
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initial research identified 115 contacts with expertise in the primary sector, the 
physical impacts of biotechnology, or the commercial impacts of specific innovations. 
The interviews were semi-structured, and sought information on the impacts of 
biotechnology on the qualities of primary products and the methods of production. 
Informants were specifically asked about adoption patterns, characteristics of markets, 
upstream and downstream impacts, and the impacts of not having biotechnology. 
Fifty-nine interviews were conducted in person, by telephone, and via email in April, 
May, and June 2005.  
 
4. Results 
Through the interviews, the present research was able to identify virtually all 
innovations of commercial importance to New Zealand relying on the four 
biotechnologies. Using primary and secondary data sources, the analysis estimated the 
direct economic value of each innovation to each subsector of the primary sector. 
The total estimated net benefit of these innovations to the primary sector is $266 
million per year, assuming constant prices. Clonal propagation / cell manipulation 
represents the largest contributor, by  virtue of its widespread and relatively long-term 
use. Biocontrol agents and enzyme man ipulations had smaller economic impacts. The 
least-commercialized biotechnology was marker-assisted selection, contributing less 
than one million dollars. 
The different contributions to the subsectors are also apparent. Dairy production 
benefited most, even without accounting for economic impacts of processing 
enzymes. This result is largely a function of the economic importance of dairy 
production. Other pastoral agriculture also benefited, with impacts on sheep 
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production larger than those on beef production. The horticulture subsector showed 
significant benefits, with some crops benefiting significantly (e.g., potatoes, 
floriculture) and others barely affected. The value of impacts in arable crops was 
relatively small, a function of the size of the subsector. Impacts were relatively small 
for forestry and nil for seafood, due to  lack of commercialized innovations. 
In addition, non-marketed benefits appeared to have been measured only rarely. There 
were suggestions from the survey and the literature about possible non-marketed 
benefits, such as environmental improvements, but little information about the exact 
impacts. Without this information, measurement of the econ omic value was 
impossible. This appears to be a potential area for future research. 
[Table 2] 
The information from informants resulted in two types of calculations. Some 
calculations represent the values of specific innovations. Informants could provide 
data on the specific production impacts, which could then be used with secondary data 
to estimate an innovation’s economic impact. The impacts of other innovations were 
not directly available in the same way. For example, informants identified increases in 
arable crop yields as a benefit of cellular biotechnology, but estimates of the size of 
the benefit relied on the literature on crop genetic gains (Abeledo et al., 2002; Bajaj, 
1990; Evenson, 2003; Traxler et al., 1995).  
The semi-structured nature of discussions with informants also yielded qualitative 
information on the impacts of biotechnology: 
· Range of impacts. The identified technologies affected both the product 
qualities and production practices. For livestock, input-oriented innovations 
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appeared to generate the greatest returns, whereas product quality innovations 
were more important for horticulture. 
· Nil results. The ‘nil’ entries in Table 2 indicate subsectors where 
biotechnologies do not appear to be producing material commercial impacts. 
Significantly, marker-assisted selection appeared to be creating little 
commercial value.  
· Extent of contributions of biotechnology. The survey did reveal the importance 
of other factors, such as natural resources, management effort, human labor, and 
machinery, in increasing returns from the primary sector. 
· Awareness of the value of innovations. Commercial considerations seemed to  
be minor factors in the research and development of many innovations 
identified.  
· Commercialization of biotechnology. Many informants distinguished between 
fundamental science and commercial application of science. Commercialization 
resulted from using fundamental science to produce usab le, convenient 
innovations within the context of a production system. Furthermore, profiting 
from commercialization required business expertise in addition to technological 
proficiency. 
Overall, these results point to uneven contributions of these biotechnologies across the 
primary sector. Some b iotechnologies are so integrated into some subsectors as to be 
unremarkable. However, since they are so integrated, their impacts are quite 
significant. Other biotechnologies do not seem to be producing large commercial 
returns, e.g., marker assisted selection. Furthermore, some parts of the primary sector 
have been barely touched by these biotechnologies.  
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5. Conclusion 
This research assessed the economic impact of the current commercial use in the 
primary sector of four biotechnologies. By choosing four specific biotechnologies and 
assessing only commercialized innovations, this research makes two contributions to 
previous studies. The first contribution is to calculate actual realized benefits, rather 
than to estimate potential future benefits. Secondly, the focus on commercially 
released technologies avoided potential issues regarding public perceptions and 
foreign market access. 
Information on the contribution of these biotechno logies is not readily available. To 
obtain data for a CBA, an extensive survey of scientists and industry experts was 
undertaken. The survey revealed that successful products are making substantial 
contributions to the sector, while a number of commercialized products are having 
more modest impacts. However, much biotechnology research has yet to produce 
measurable economic value, and some parts of the primary sector are essentially 
unaffected by these biotechno logies.  
A CBA was performed using information from this survey as well as secondary data 
sources. The annual direct impact of these biotechnologies to the New Zealand 
primary sector was estimated at $266 million. The sectors with the largest impacts 
were dairy, sheep, and horticulture. The biotechnology with the largest impact was 
clonal propagation / cellular manipulation, while marker assisted selection had the 
least impact. 
The discussions with key informants yielded valuable qualitative insights. Informants 
emphasized that individual innovations are the products of long-term, fundamental 
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research. The subsectors in which specific biotechnologies are not producing 
commercial returns can easily be viewed in this context: the fundament al science is 
being undertaken but has no t yet been applied commercially.  
The analysis reported in this paper did not account for changes in commodity prices 
as a result of increased productivity, but assumed that New Zealand is a price-taker 
for all commodities. This assumption is not likely to hold, so an extension of this 
research would account for the impacts of p roductivity gains on prices. 
This economic analysis is also based on reports by informed persons of the impacts 
that biotechnology has had on primary production over the last 20 to 25 years. Where 
possible, these reported impacts have been confirmed with published sources. 
However, one weakness with this analysis is its reliance on perceptions rather than 
measurements o f the contributions of biotechnology. Similarly, the counterfactual 
scenarios relied on reports of how production would be likely to happen in the 
absence of biotechnology. Relying on this information contributes some uncertainty 
to these calculations. 
Nevertheless, the authors believe that reliance on industry experts is also a strength of 
this research. This analysis has attempted to decompose the impact of biotechnology 
on the primary sector into its constituent elements: what has been the economic 
impact of this specific technology on this crop o r product? This decomposition was 
necessary in order to survey informants. As a result, the survey produced some 
unanticipated findings. One such finding was that the focus on economic impacts (as 
opposed to  laboratory results) appeared foreign to many informants. A second 
unanticipated finding was that commercial gains are yet to be realized in some areas.  
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This research provides a baseline estimate of the contribution of specific 
biotechnologies to New Zealand’s primary sector. Future research can use these 
results to compare them with other biotechnologies or to determine the value of 
subsequent technological developments. 
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Figure 1. Biotechnology impacts in two dimensions 
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Table 1. New Zealand’s primary sector* 
Subsector Physical measure of production 
Value of 
production 
($ million) 
Value of 
exports** 
($ million) 
Dairy 
5.11 million head, 
1.2 billion kgs of 
milksolids 
5,300 5,800 
Beef and veal 4.64 million head 1,300 1,900 
Sheep (meat & wool) 39.7 million head 2,800 3,000 
Horticulture 110,000 hectares 4,500 2,100 
Forestry 20,888,000 m3 3,900 3,200 
Arable over 179,000 hectares 389 111 
Seafood 750,000 tons 1,340 1,200 
* Figures fo r each subsector are no t directly comparable with each other, but are only 
representative. Sources: (Burtt, 2004; HortResearch, 2003; Ministry of Agriculture and Forestry, 
2003, 2004a, b, c; Ministry of Fisheries, 2004; Statistics New Zealand, 2004, 2005a, b). 
** Value of exports can exceed value of production due to processing of raw products. 
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Table 2. Summary of direct impacts of four biotechnologies 
Subsector 
Value of clonal 
propagation / 
cell 
manipulation 
($000’s) 
Value of 
biocontrol 
agents 
($000’s) 
Value of 
enzyme 
manipulations 
($000’s) 
Value of 
marker 
assisted 
selection 
($000’s) 
Total 
($000’s) 
Dairy 74,914 19,893 3,791 nil 98,598 
Beef and veal 20,890 772 nil nil 21,662 
Sheep (meat 
and wool) 35,287 41,353 nil 770 77,410 
Forestry 16,976 nil nil nil 16,976 
Horticulture 
and floriculture 32,995 small value 9,960 nil 42,955 
Arable crops 8,220 nil nil nil 8,220 
Seafood nil nil nil nil 0 
Total 189,282 62,018 13,751 770 265,821 
